Government partners decry stigmatization of people living with leprosy

Abuja, 1 February, 2022 – In commemoration of the 2022 World Leprosy Day, the Government of Nigeria and Partners have decried the continuous stigmatization of people living with the disease.

The Honorable Minister of Health, Dr Osagie Ehanire, speaking at a ministerial press briefing to mark the day in Abuja on 31st of January 2022, said stigmatization continues to have negative impact to the successful elimination of the disease and re-integration of those cured back into their communities.

Dr Ehanire noted that leprosy is a public health issue and puts the country among the last nations in the world to defeat the disease, with more than 1,000 new cases still reported in a year. 

In 2020, Nigeria notified 1,508 new cases, of which over 13% had a visible deformity of fingers and toes, and more than 6 % were children. 

“Efforts to combat the disease is still affected by challenges. Stigma and discrimination against persons affected by leprosy and their families remains a challenge. The wrong beliefs that it is contagious, hereditary or ordained punishment and the fear of rejection by family and friends, deter victims from seeking early care if they suspect leprosy and discourage those cured of integration back into their communities. 

The commemoration of the 2022 World Leprosy Day draws attention to the plight of fellow citizens living with the age-old disease. We mark this occasion again with a review of Nigeria’s efforts to end the disease. About 18 states are still witnessing its features as an endemic disease in the whole country, he said. 

In his goodwill remark, the WHO Country Representative (WR), Dr Walter Kazadi Mulombo, appreciated Nigeria’s efforts on the Leprosy Programming, saying the country is not yet out of the woods as it remains important in the global Leprosy eradication road map. 

The WR said the notification of new cases and the Grade 2 disability is a problem among patients as cases could be prevented by early diagnosis, contact tracing and ensuring adherence to treatment.

He added this year’s theme “United for dignity”, emphasizes the need for increased collaboration by all stakeholders to put hands together to ensure increased efforts towards elimination of Leprosy and prevention of the disabilities it causes. 

WHO’s Commitment 

Dr Mulombo pledged WHO’s commitment to collaborate with other key partners to step-up action in supporting the Federal Ministry of Health to mobilize the needed domestic and international resources required for the control, elimination and eradication of Leprosy and other neglected tropical diseases in the country. 

He said WHO is also committed to facilitating the donation of all needed medicines for Leprosy as it has always done each year.

“Finally, I want to encourage individuals, communities, and local governments to encourage surveillance, testing and treatment for leprosy and to learn more about this disease, to end the silent epidemic”, he added.

World Leprosy Day is marked annually on the last Sunday in January. Leprosy or Hansen’s disease is a chronic infectious disease caused by a slow-growing bacterium, Mycobacterium leprae (M. leprae). “It is an age-old disease, described in the literature of ancient civilizations. Throughout history, people afflicted have often been ostracized by their communities and families”.

The commemoration is aimed at celebrating people who have experienced leprosy, raising awareness about the disease, and calling for an end to leprosy-related stigma and discrimination.

Technical contact:

Dr Anne Jean Baptiste; Email: jeana [at] who.int

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
FDA Approves Faricimab for nAMD and Diabetic Macular Edema thumbnail

FDA Approves Faricimab for nAMD and Diabetic Macular Edema

The US Food and Drug Administration (FDA) today approved faricimab (Vabysmo, Genentech/Roche) to treat diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD). Compared with antivascular endothelial growth factor (VEGF) drugs currently in use, faricimab requires fewer intravitreal injections on average, so it may reduce the burden on both patients and their physicians while…
Read More
Building momentum against diphtheria outbreak in Nigeria thumbnail

Building momentum against diphtheria outbreak in Nigeria

Abuja ‒ When his seven-year-old brother Jubrin was diagnosed with diphtheria in July 2023, Aminu Dayyabu Alharini had never heard of the disease, the latest outbreak of which has claimed more than 500 lives in Nigeria. Following the diagnosis, Jubrin was immediately transferred from the health facility near their home in Alharini settlement, in Kano
Read More
Dual-Chamber Leadless Pacemaker Impresses in Safety-and-Performance Study thumbnail

Dual-Chamber Leadless Pacemaker Impresses in Safety-and-Performance Study

Meeting Coverage > HRS — Device provided atrial pacing, reliable atrioventricular synchrony for 3 months post-implantation by Ed Susman, Contributing Writer, MedPage Today May 21, 2023 NEW ORLEANS -- A leadless dual-chamber pacemaker with bidirectional wireless communication turned in very promising short-term results in patients with standard indications for dual-chamber pacing, according to the Aveir
Read More
Mini Pizzas thumbnail

Mini Pizzas

Mini Pizzas By: WellBeing Team At The Organic Milk Co., it is the valued relationships with suppliers, customers and the communities they serve that make it all possible. Ingredients Tomato pizza sauce 6 mini pizza bases Organic Milk Co. Shredded Organic Cheddar Pineapple chunks Cooked ham (optional) Olive oil Basil Method Add 1 tsp tomato
Read More
Index Of News
Total
0
Share